NewSenior Oncology Account Manager (OAM) – South Region-Remote-Nashville, Tennessee IDEAYA BiosciencesSenior Oncology Account Manager (OAM) – South Region-Remote-Nashville, TennesseeTennesseeRemoteThe final salary offered to a successful candidate will depend on several factors that may include but are not limited to the office location where this open position is located, the final candidates’ experience within their profession, experience in the disease areas we are striving to make an impact in as a company, length of time within the industry, educational background, and performance during the interview process. Along with our inspiring mission, and highly collaborative and inclusive environment, IDEAYA offers a competitive total rewards package that reflects our pay-for-performance philosophy where employees are eligible to be considered for merit-based salary increases, company discretionary short-term incentive plan participation, and company discretionary stock option awards (based on board approval).
Senior Computational Research Scientist St. Jude Children's Research Hospital IncSenior Computational Research ScientistMemphis, TNRemote$104,000–$186,160 / yearThe Department of Chemical Biology and Therapeutics (CBT) is seeking a highly motivated computational chemist interested in using state-of-the-art techniques in computer-aided drug design, virtual screens, and structure-guided drug design to discover novel small molecule modulators of targets relevant to pediatric disease. The applicant is expected to work alongside domain experts in the biology of pediatric disease, chemists, and pharmacologists, as well as the various institutional shared resources devoted to translational science, in a collaborative project team environment.
NewSenior Quantitative Scientist, Implementation Verana Health IncSenior Quantitative Scientist, ImplementationKnoxville, TNRemote$141,441–$176,801 / yearVerana Health, a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network, recently secured a $150 million Series E led by Johnson & Johnson Innovation - JJDC, Inc. (JJDC) and Novo Growth, the growth-stage investment arm of Novo Holdings. The Data & Science team's work directly improves quality of care for patients, and your technical leadership will help us harness data's full potential-ensuring clinical insights translate into better health outcomes.